MOTAGON receives EU-GMP certification

MOTAGON receives EU-GMP certification

Motagon has been issued by the State Institute for Drug Control (SUKL) a certificate of EU-GMP compliance of a manufacturer for active substances. The inspection was conducted on 30.08.2022, and the State Agency for Drug Control concluded that “From the...
Motagon introduces GG4 medical cannabis to the Czech market

Motagon introduces GG4 medical cannabis to the Czech market

Motagon Cannabis, a subsidiary of international pharma company HEATON Group a.s., brings GG4 (Gorilla Glue 4), a high-THC medical cannabis flower, to patients in Czechia. Prague, Czechia, September 9, 2021 – Motagon Cannabis (“Motagon”), a subsidiary of international...